Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Kidney Foundation, Singapore | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Hemodialysis patients often experience barriers and misperceptions that hinder adjustment to life on dialysis. This study seeks to explore a group-based intervention (titled HED-Start) developed to improve self-care and emotional wellbeing among incident hemodialysis patients.
There are potentially modifiable psychosocial barriers and misperceptions about life on dialysis that hinder adjustment outcomes. It is hypothesized that these may include: poor understanding on what is needed or 'how to implement treatment principles', misperceptions related to disease and treatment, catastrophizing beliefs about impact of dialysis and low level of confidence on ability to manage treatment regime and renegotiate life roles as a "dialysis patient".
This study seeks to explore the feasibility and acceptability of implementing a two-arm parallel randomized controlled trial of a group-based intervention (titled HED-Start). HED-Start is specifically developed to reduce psychological distress and support self-care and self-management outcomes in incident hemodialysis patients.
Drawing on self-management and motivational interviewing principles paradigm, the HED-Start program aims to facilitate acquisition of skills and knowledge to support and improve self-care and emotional adjustment outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HED-Start Intervention arm | Experimental | Participants assigned to the intervention arm will undergo 4 sessions of the HED-Start program. Each session is 2 hours long and will be conducted fortnightly. |
|
| Standard care arm | No Intervention | Participants assigned to the standard care arm will proceed with routine standard care. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HED-Start | Behavioral | The HED-Start Program is a cognitive-behavioral intervention based on self-management and motivational interviewing principles. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Anxiety and Depression (HADS) scores from baseline | Hospital Anxiety and Depression Scale (HADS). The HADS comprises two subscales (anxiety; depression) and can be totaled to produce an overall scale score. Scores range from 0 to 21 for each subscale, and from 0 to 42 for the overall score. Higher scores are indicative of worse anxiety and depression symptoms. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Quality of life (WHOQOL-BREF) scores from baseline | World Health Organization Quality of Life instrument (WHOQOL-BREF). Two global items (overall quality of life; general health) and two subscales (psychological health; social relationships) from the WHOQOL-BREF are used. Global scores range from 1 to 5, while subscale scores range from 4 to 20. Higher scores indicate better quality of life. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Konstadina Griva, PhD | Contact | +6569047348 | konstadina.griva@ntu.edu.sg |
| Name | Affiliation | Role |
|---|---|---|
| Konstadina Griva, PhD | Nanyang Technological University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Kidney Foundation Singapore | Recruiting | Singapore | Singapore |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34548369 | Derived | Griva K, Chia JMX, Goh ZZS, Wong YP, Loei J, Thach TQ, Chua WB, Khan BA. Effectiveness of a brief positive skills intervention to improve psychological adjustment in patients with end-stage kidney disease newly initiated on haemodialysis: protocol for a randomised controlled trial (HED-Start). BMJ Open. 2021 Sep 21;11(9):e053588. doi: 10.1136/bmjopen-2021-053588. |
Not provided
Not provided
All deidentified IPD that underlie results in a publication will be available upon reasonable request.
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007676 | Kidney Failure, Chronic |
| ID | Term |
|---|---|
| D051436 | Renal Insufficiency, Chronic |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Care providers (dialysis nurses) and outcomes assessors (research staff conducting the baseline and follow-up questionnaires) will be blinded to participant allocation.
| Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Change in kidney disease-related quality of life (KDQOL-SF) scores from baseline | Kidney Disease Quality of Life instrument (KDQOL-SF). The Burden of Kidney Disease subscale from the KDQOL-SF will be administered. Scores range from 0 to 100, with a higher score reflecting better quality of life. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Change in Illness Perception scores from baseline | Brief Illness Perception Questionnaire (BIPQ). The BIPQ consists of 8 subscales (i.e., Consequence, Timeline, Identity, Personal Control, Treatment Control, Concern, Coherence, and Emotional Representation). Subscale scores range from 0 to 10, with higher scores reflective of more negative illness perceptions. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Change in Positive and Negative Affect scores from baseline | Scale of Positive and Negative Experience (SPANE). The SPANE comprises 6 items assessing positive affect and 6 items assessing negative affect. Subscale scores range from 6 to 30. Higher scores in the Positive and Negative affect subscale indicate greater positive and negative affect respectively. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Change in Self-Efficacy for Managing Chronic Disease 6-item Scale scores from baseline | Self-Efficacy for Managing Chronic Disease 6-item Scale. The overall scale score ranges from 1 to 10. Higher scores reflect greater self-efficacy. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Change in Benefit finding in hemodialysis (BFS) scores from baseline | Benefit Finding Scale (BFS). Two subscales (personal growth; acceptance) and an overall score can be computed. All scores range from 1 to 4, with a higher score reflecting a greater extent of benefit finding. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Change in Resilience scores from baseline | 2-item Connor-Davidson Resilience Scale (CD-RISC-2). The CD-RISC-2 score ranges from 0 to 8. Higher scores indicate greater resilience. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| Change in Health Education Impact Questionnaire scores from baseline | Health Education Impact Questionnaire (heiQ). Six subscales from the heiQ (Positive and Active Engagement in Life, Skill and Technique Acquisition, Constructive Attitudes and Approaches, Self-Monitoring and Insight, Health Services Navigation, and Social Integration and Support) will be used to assess other self-management skills. Scores range from 1 to 4. Higher scores indicate greater proficiency with the relevant skill domain. | Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization |
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |